Bonumose

Bonumose is a biotechnology company specializing in the production of rare sugars, particularly tagatose, through innovative enzymatic processes. The company operates in the health and wellness market, focusing on providing healthier alternatives to traditional sugars. Bonumose's primary clients include food and beverage manufacturers looking to reduce sugar content in their products without compromising taste. The company's business model revolves around scaling up the production of tagatose and other rare sugars to commercial levels, thereby making these healthier sweeteners more accessible and affordable. Revenue is generated through the sale of these rare sugars to manufacturers and potentially through licensing their proprietary enzymatic technology. Bonumose aims to expand its portfolio to include a variety of functional food ingredients, further enhancing its market presence and impact on public health.

Keywords: rare sugars, tagatose, enzymatic production, health, wellness, food ingredients, biotechnology, sugar reduction, commercial scaling, affordable sweeteners.